Fundz

Mirum Pharmaceuticals secures $68.5 million in a private placement financing led by TCGX to support clinical development and acquisition activities.

PUBLIC · MIRMDec 19, 2025

Amount Raised

$68.5 Million

Round Type

Post-IPO Equity

Foster CityHealthcarePharmaceutical Manufacturing

Investors

Tcgx

Description

Mirum Pharmaceuticals has entered into a subscription agreement for a private placement of 1,000,000 shares at $68.48 per share, totaling approximately $68.5 million. The funds will be used for clinical development and commercial strategies following the proposed acquisition of Bluejay Therapeutics. This acquisition is anticipated to close in the first quarter of 2026. The private placement is part of a larger financing strategy involving another recent private placement.

Quick answer

Mirum Pharmaceuticals, Inc. raised $68.5 Million in a Post-IPO Equity round, dated December 19, 2025. Investors: Tcgx. Mirum Pharmaceuticals, Inc. is based in Foster City, California, United States.

How much did Mirum Pharmaceuticals, Inc. raise?
Mirum Pharmaceuticals, Inc. raised $68.5 Million in a Post-IPO Equity round on December 19, 2025.
Who invested in Mirum Pharmaceuticals, Inc?
Tcgx is named as investors in this round.
What does Mirum Pharmaceuticals, Inc. do?
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults.
Where is Mirum Pharmaceuticals, Inc. based and how big is it?
Mirum Pharmaceuticals, Inc. is based in Foster City, California, United States.
Who are the decision-makers at Mirum Pharmaceuticals, Inc?
Fundz holds 1 contact at Mirum Pharmaceuticals, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Pharmaceutical Manufacturing around the same time

Companies in the same sectors as Mirum Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Lexicon Pharmaceuticals raised $56M on February 2, 2026.
  • Doc.com raised $1.5M (Seed) on February 2, 2026.
  • NexEos Diagnostics, Inc. raised $3M on February 2, 2026.
  • Corus Orthodontists raised $16M on February 2, 2026.
  • Light Wave Ownership Path raised $61K on January 31, 2026.
  • Light Wave Holding Company raised $2.9M on January 31, 2026.

Who to call at Mirum Pharmaceuticals, Inc., and when

A new round usually means Mirum Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mirum Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mirum Pharmaceuticals, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mirum Pharmaceuticals, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mirum Pharmaceuticals, Inc.

Location

989 East Hillsdale Boulevard, Suite 300

Foster City, California, United States

About

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat) oral solution, Cholbam® (cholic acid) capsules, and Chenodal® (chenodiol) tablets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mirum Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts7 people are listed at Mirum Pharmaceuticals, In…. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Mirum Pharmaceuticals, Inc.'s next move

See what Strategic adds

Mirum Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.